State of Tennessee, Department of Treasury’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-91,019
Closed -$10.2M 1720
2021
Q4
$10.2M Buy
+91,019
New +$11M 0.04% 338
2021
Q1
Sell
-22,000
Closed -$3.1M 1671
2020
Q4
$3.1M Buy
+22,000
New +$2.82M 0.01% 659
2018
Q3
Sell
-457,515
Closed -$43.6M 1606
2018
Q2
$43.6M Buy
457,515
+254,505
+125% +$23.4M 0.22% 113
2018
Q1
$17.8M Buy
203,010
+61,410
+43% +$5.61M 0.09% 225
2017
Q4
$12M Buy
+141,600
New +$11.9M 0.05% 316
2017
Q2
Sell
-72,360
Closed -$5.02M 1526
2017
Q1
$5.02M Buy
+72,360
New +$4.86M 0.02% 558

Other funds holding XBI

State of Tennessee, Department of Treasury's XBI Position: Q1 2022 in Review

State of Tennessee, Department of Treasury sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2022, closing a stake of 91,019 shares — an estimated $10.2M sold.

State of Tennessee, Department of Treasury first reported a position in XBI in Q1 2017 and held it in 6 quarters. The position peaked at $43.6M in Q2 2018. 703 funds tracked by Wall St. Rank hold XBI as of Q1 2022.

  • State of Tennessee, Department of Treasury reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2022 after selling out during the quarter.
  • State of Tennessee, Department of Treasury sold 91,019 State Street SPDR S&P Biotech ETF shares in Q1 2022, an estimated $10.2M.
  • State of Tennessee, Department of Treasury first reported a position in State Street SPDR S&P Biotech ETF in Q1 2017 and held it in 6 quarters.
  • State of Tennessee, Department of Treasury's State Street SPDR S&P Biotech ETF position peaked at $43.6M in Q2 2018.
  • 703 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2022.

Based on State of Tennessee, Department of Treasury's 13F filing for Q1 2022, filed 11 May 2022.